Polatuzumab Vedotin-piiq and Roweepra

• Generic Name: polatuzumab vedotin
• Dosage Forms: n.a.
• Other Brand Names: Polivy

Polatuzumab vedotin-piiq is a CD79b-directed antibody–drug conjugate indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies.

Accelerated approval was granted for this indication based on complete response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

• Generic Name: levetiracetam
• Dosage Forms: tablet, film coated
• Other Brand Names: Keppra, Keppra XR, Roweepra, Spritam, Roweepra XR

Roweepra is used to treat partial onset seizures in adults and children who are at least 1 month old. The Spritam brand of Roweepra is not for use in children younger than 4 years old or children who weigh less than 44 pounds.

Roweepra is also used to treat tonic-clonic seizures in people who are at least 6 years old, and myoclonic seizures in people who are at least 12 years old.

Roweepra may also be used for purposes not listed in this medication guide.